Active, not recruitingPhase 3NCT06007183

Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination

Studying Chikungunya

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Bavarian Nordic
Principal Investigator
Patrick Ajiboye, MD
Bavarian Nordic
Intervention
CHIKV VLP vaccine booster(biological)
Enrollment
800 enrolled
Eligibility
12 years · All sexes
Timeline
2023 – 2028

Study locations (24)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06007183 on ClinicalTrials.gov

Other trials for Chikungunya

Additional recruiting or active studies for the same condition.

See all trials for Chikungunya →

← Back to all trials